Palisade Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Palisade Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-428,810	Closed	-$15.1M	–	556
2015 Q1	$15.1M	Buy	428,810 +1,224	+0.3%	+$41.4K	0.38%	79
2014 Q4	$13.7M	Sell	427,586 -13,206	-3%	-$382K	0.33%	102
2014 Q3	$12.4M	Sell	440,792 -78,298	-15%	-$2.38M	0.31%	106
2014 Q2	$15.7M	Buy	519,090 +95,782	+23%	+$2.64M	0.38%	90
2014 Q1	$11.7M	Sell	423,308 -61,657	-13%	-$1.61M	0.29%	137
2013 Q4	$12.4M	Sell	484,965 -129,202	-21%	-$3.98M	0.32%	122
2013 Q3	$18.4M	Sell	614,167 -950	-0.2%	-$26.4K	0.5%	57
2013 Q2	$17.7M	Buy	+615,117	New	+$16.9M	0.51%	54

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Palisade Capital Management's BRLI Position: Q2 2015 in Review

Palisade Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 428,810 shares — an estimated $15.1M sold.

Palisade Capital Management first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $18.4M in Q3 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Palisade Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Palisade Capital Management sold 428,810 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $15.1M.
Palisade Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Palisade Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $18.4M in Q3 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Palisade Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.